Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications
CA 1182811 A · Owner: Institut Pasteur · Inventors: Bizzini, Bernard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A new thiolated polypeptide compound derived from a fragment of tetanus toxin, the process for its obtention and its applications. This compound consists of the IIc fragment of tetanus toxin,having at least one. -SH group either directly or Indirectly bound thereto. It is usable as a specific neuropharmacological transport agent for transporting a medicine to the central nervous system,as a specific labeller for neuronal cells or or diagnosis purposes. It can be coupled with a medicine or a labeller.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 19, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 19, 2002.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.